GENE ONLINE|News &
Opinion
Blog

Neurological Disorder
Technology Brain-Computer InterfaceNeuroscience
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
M&A m&aBristol Myers SquibbKaruna TherapeuticsNeuroscience
Bristol Myers Squibb Acquires Karuna Therapeutics to Enhance Neuroscience Portfolio
2023-12-25
M&A Neuromuscular Disorder
Novartis Acquires DTx Pharma and Expands Its Neuroscience Pipeline
2023-07-20
R&D Amyotrophic Lateral Sclerosis
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
Licensing Neurological Disorder
Denali Taps PharmEnable to Discover AI-Based Small Molecule Candidates for Neurological Diseases
2022-05-30
R&D Biomarker
Australian Researchers Discover First Biomarker for Sudden Infant Death Syndrome
2022-05-18
Funding Neurological Disorder
Axial Therapeutics to Advance Pipeline for Neurological Diseases with $37.25 Million Series C Funding
2021-10-17
M&A
Supernus Invests $400 Million to Acquire New Parkinson’s Assets from Adamas
2021-10-12
Asia-Pacific
Japan’s Otsuka Inks $890M Deal with Sunovion to Target Neurological Illness
2021-10-01
Deals
Harmony Acquires New Asset for $3.5 Million to Treat Rare Neurological Diseases
2021-08-11
COVID-19
COVID-19: FDA Adds New Warning For a Rare Autoimmune Disorder to J&J’s Vaccine
2021-07-14
Startups AAV
Setting its Sights on Neurological Disorders, CRISPR Therapeutics Turns to an AAV Startup That Just Emerged Out of Stealth
2021-06-16
Trials & Approvals
Pfizer’s Panzyga Receives FDA Approval for Rare Neurological Disease
2021-02-17
Feature Cannabidiol
Spotlight: Cannabidiol (CBD) Based Medication Heralds New Promise in Neurological Therapies
2020-09-22
In-Depth
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
1 2
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top